Abbott Laboratories
ABT
A$201.67
Share price
-0.02%
Change (1 day)
32.48%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Net assets
Net assets on the balance sheet as of March 2025 : A$75.29 Billion
According to Abbott Laboratories's latest financial reports the company has A$75.29 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Abbott Laboratories - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $A$77.01 B | 35.13% |
| 2023-12-31 | $A$56.98 B | 5.08% |
| 2022-12-31 | $A$54.23 B | 9.14% |
| 2021-12-31 | $A$49.68 B | 15.77% |
| 2020-12-31 | $A$42.92 B | -4% |
| 2019-12-31 | $A$44.70 B | 2.52% |
| 2018-12-31 | $A$43.60 B | 9.48% |
| 2017-12-31 | $A$39.83 B | 38.6% |
| 2016-12-31 | $A$28.74 B | -1.82% |
| 2015-12-31 | $A$29.27 B | 10.72% |
| 2014-12-31 | $A$26.44 B | -6.66% |
| 2013-12-31 | $A$28.32 B | 9.79% |
| 2012-12-31 | $A$25.80 B | 7.87% |
| 2011-12-31 | $A$23.91 B | 6.73% |
| 2010-12-31 | $A$22.41 B | -12.08% |
| 2009-12-31 | $A$25.49 B | 2.66% |
| 2008-12-31 | $A$24.83 B | 22.11% |
| 2007-12-31 | $A$20.33 B | 14.06% |
| 2006-12-31 | $A$17.82 B | -9.5% |
| 2005-12-31 | $A$19.70 B | 6.42% |
| 2004-12-31 | $A$18.51 B | 5.26% |
| 2003-12-31 | $A$17.58 B | -7.09% |
| 2002-12-31 | $A$18.92 B | 6.63% |
| 2001-12-31 | $A$17.75 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | A$119.87 B | 59.20% | 🇺🇸 USA |
 Pfizer PFE | A$139.09 B | 84.73% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | A$75.94 B | 0.86% | 🇺🇸 USA |
 Hologic HOLX | A$7.08 B | -90.59% | 🇺🇸 USA |
 Medtronic MDT | A$74.05 B | -1.65% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | A$26.77 B | -64.44% | 🇺🇸 USA |
 Boston Scientific BSX | A$34.44 B | -54.25% | 🇺🇸 USA |
 AstraZeneca AZN | A$63.12 B | -16.17% | 🇬🇧 UK |
 Novartis NVS | A$59.01 B | -21.63% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | A$27.07 B | -64.04% | 🇬🇧 UK |